Dengue virus belongs to family Flaviviridae, having four serotypes that spread by the bite of
infected Aedes mosquitoes. It causes a wide spectrum of illness from mild asymptomatic …

Dengue viruses (DENV) are the most important human arboviral pathogens. Transmission in
tropical and subtropical regions of the world includes a sylvatic, enzootic cycle between …

Dengue virus causes leakage of the vascular endothelium, resulting in dengue hemorrhagic
fever and dengue shock syndrome. The endothelial cell lining of the vasculature regulates …

A dengue vaccine should induce long-lasting, simultaneous protection to the four dengue
viruses while avoiding the immune enhancement of viral infection. Domain III of the dengue …

Dengue viruses are emerging mosquito-borne pathogens belonging to Flaviviridae family
which are transmitted to humans via the bites of infected mosquitoes Aedes aegypti and …

Dengue viruses co-circulate as four serologically distinct viruses (DENV1–4) that commonly
infect individuals sequentially. Current DENV candidate vaccines incorporate the entire …

Dengue fever, a mosquito borne viral disease, has become a major public health problem
with dramatic expansion in recent decades. Several dengue vaccines are at developing …

Dengue is the most important arthropod-borne viral disease in humans, with an estimated
3.6 billion people at risk for infection and more than 200 million infections per year …

Dengue is caused by a taxonomic group of four viruses, dengue virus types 1–4 (DENV1–
DENV4). A molecular understanding of the antibody-mediated protection against this …

CD16-RIgE is a chimeric human membrane glycoprotein consisting of the CD16 ectodomain
fused to the transmembrane domain and cytoplasmic tail of the gamma chain of the high …